Research Funding

Emaad Abdel-Rahman, MBBSCV185-450RENal hemodialysis patients Allocated apixaban versus warfarin in Atrial Fibrillatio (RENAL-AF)04/10/18 - 04/09/21
Emaad Abdel-Rahman, MBBS17530-14248A randomized, double-blind, placebo-controlled, parallel-group, multicenter, eventdriven Phase III study to investigate the efficacy and safety of finerenone on the reduction of cardiovascular morbidity and mortality in subjects05/02/18 - 05/01/21
Emaad Abdel-Rahman, MBBS16244-14248A randomized, double-blind, placebo-controlled, parallel-group, multicenter, eventdriven Phase III study to investigate the efficacy and safety of finerenone / Bayer Study 1624405/02/18 - 05/01/21
Emaad Abdel-Rahman, MBBSSafety and Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for Hemodialysis4/23/14 - 9/18/19
Brendan Bowman, MDCenter for Innovative TechnologyOptimizing Anemia Dosing Algorithms by Leveraging EMR Data to Improve Outcomes in End Stage Renal Disease7/1/18 - 3/31/20
Michael G. Brown, PhDNIH/NAIAD 5R01AI050072-17Molecular study mouse virus resistance mechanisms2/22/17 - 1/31/22
Michael G. Brown, PhDNIH/NAIAD 1R21AI141943-01A1TNFRSF Genetics Related to NK Cell Control of MCMV6/1/19 - 5/31/21
Tushar Chopra, MDASN - Bennett Clinical ScholarsPD curriculum development to improve PD prescriptions writing.7/1/19 - 6/30/21
Alden Doyle, MDSN-C-0010
Evaluation of patient outcomes from the Kidney allograft outcomes allosure registry (KOAR) agreement04/23/18-06/01/21
Uta Erdbruegger, MDNIH/NHLBI 5K23HL126101-05Circulating and urinary microparticles as markers of end-organ damage in hypertension7/20/15 - 4/30/20
Uta Erdbruegger, MDAmerican Heart AssociationFellowship (Sabrina La Salvia) Subtypes of Leukocytes derived Extracellular Vesicles in Hypertension7/1/18 - 6/30/20
Shuman Fu, MDNIH 5R01AR047988-18Cellular and Genetic Basis of Systemic Lupus 4/22/16 - 3/31/21
Shuman Fu, MDLupus Research AllianceLocal Factors Contributing to Pathogenesis of Proliferative Lupus Nephritis1/1/17 - 9/30/20
Shuman Fu, MDNIH/NIAID 5R01AI139673-02Infections, Microbiome and HLA-DR in the Induction of Lupus Related Auto-antibodies8/10/18 - 7/31/23
Kambiz Kalantari, MDST-001-CALISTAHope Pharma: Calciphylaxis Study04/27/18-04/26/21
Sana Khan, MDArbor Research Collaborative for HealthThe Peritoneal Dialysis Outcomes and Practice Patterns Study (PDOPPS)1/14/19 - 1/13/22
Peter Lobo, MDR01DK114366-01A1CpG and B cells, pretreated ex-vivo with natural IgM, protect against renal IRI05/02/18 - 03/31/22
Mark D. Okusa, MD5 T32 DK072922Kidney Disease and Inflammation08/01/06 -08/31/21
Mark D. Okusa, MDNIH/NIDDK 5R01DK085259-08Sphingolipids in Acute Kidney Injury and Disease Progression7/1/15 - 6/30/20
Mark D. Okusa, MDNIHI/NIDDK 5R01DK105133-05Ultrasound for Non-Invasive Prevention of Acute Kidney Injury9/21/15 - 7/31/20
Mark D. Okusa, MDPfizer Inc. Am-Pharma Mode of Action of Recap in Renal Mouse Mode3/21/16 - 11/20/19
Mark D. Okusa, MDASN - Ben Lipps FellowshipNabin Poudel Fellowship - Pannexin 1 And Acute Kidney Injury7/1/19 - 6/30/21
Mitchell Rosner, MDOtsuka Phrmaceutical Development and ComercializationOtsuka Tolvaptan Polycystic Kidney Disease (OPC-41061)9/1/14 - 1/31/20
Mitchell Rosner, MDKadmon Corporation, LLC KD019-211A Double-blind Randomized Parallel Group Study of the Efficacy and Safety of Tesevatinib in Subjects with Autosomal Dominant Polycystic Kidney Disease12/1/17 - 11/30/20
Mitchell Rosner, MDKadmon Corporation, LLC KD019-extProtocol KD019-101 Extension1/4/16 - 11/30/20
Julia Scialla, MDNIH/NIDDK R01 DK111952Integrated Mineral Metabolism Treatment Strategies in Patients on Dialysis7/1/19 - 2/28/21
Rahul Sharma, PhDNIH/NIDDK 5R01DK104963-04Regulatory T Cells in Acute Kidney Injury12/15/15 - 11/30/20
Rahul Sharma, PhDNIH/Wake Forrest UniversityThe TREX1 Pathway in Autoimmune Disease1/1/16 - 12/31/19
Rahul Sharma, PhDNIH/NIDDK 5R01DK105833-04Targeting Treg for Therapy of Lupus Glomerulonephritis3/1/16 - 2/29/20
Sundararaman Swaminathan, MDNIH/NIDDK 5R01DK103043-04Targeting Cellular Iron Dnamics for Protection in Kidney Injury7/13/15 - 6/30/20